FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 358:716-727 February 14, 2008 Number 7 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF PDA Full Text PowerPoint Slide Set CME Exam Purchase this article Letters Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited E-mail When Letters Appear PubMed Citation

Acute lower respiratory tract infections are a persistent and pervasive public health problem. They cause a greater burden of disease worldwide than human immunodeficiency virus infection, malaria, cancer, or heart attacks.¹ In the United States, they cause more disease and death than any other infection, and there has been little change in mortality due to respiratory tract infection for more than five decades.^1,2 The outcome of an acute lower respiratory tract infection depends on the virulence of the organism and the inflammatory response in the lung. When small numbers of low-virulence microbes are deposited in the lungs, an effective defense . . . [Full Text of this Article]

Inflammation and Innate Immunity

Generation of Acute Inflammation in Infected Lungs

Molecules That Detect Microbes

Sentinel Cells in the Lungs

Effectors of Innate Immunity

Inflammation and Acute Lung Injury

Regulation of Acute Inflammation in Infected Lungs

Responses of Microbes to Inflammation

Genetic Variation in Inflammatory Pathways

Conclusions

Source Information

From the Molecular and Integrative Physiological Sciences Program, Harvard School of Public Health, Boston.

Address reprint requests to Dr. Mizgerd at Molecular and Integrative Physiological Sciences, Harvard School of Public Health, 665 Huntington Ave., Boston, MA 02115, or at jmizgerd@hsph.harvard.edu.

Related Letters:

Acute Lower Respiratory Tract Infection
Eisenhut M., Mizgerd J. P.
Extract | Full Text | PDF  
N Engl J Med 2008; 358:2413-2414, May 29, 2008. Correspondence

This article has been cited by other articles:

• Hirche, T. O., Benabid, R., Deslee, G., Gangloff, S., Achilefu, S., Guenounou, M., Lebargy, F., Hancock, R. E., Belaaouaj, A. (2008). Neutrophil Elastase Mediates Innate Host Protection against Pseudomonas aeruginosa. J. Immunol. 181: 4945-4954 [Abstract] [Full Text]  
• Serezani, C. H., Ballinger, M. N., Aronoff, D. M., Peters-Golden, M. (2008). Cyclic AMP: Master Regulator of Innate Immune Cell Function. Am. J. Respir. Cell Mol. Bio. 39: 127-132 [Abstract] [Full Text]  
• Annane, D., Umberto Meduri, G., Marik, P. (2008). Critical illness-related corticosteroid insufficiency and community-acquired pneumonia: back to the future!. Eur Respir J 31: 1150-1152 [Full Text]  
• Eisenhut, M., Mizgerd, J. P. (2008). Acute Lower Respiratory Tract Infection. NEJM 358: 2413-2414 [Full Text]